HOME >> BIOLOGY >> NEWS
Researchers identify protein linked to tumor invasion

BOSTON A protein known for its role in helping to provide the body's immune system with a line of defense against infection has unexpectedly been discovered in cancer cells that were removed from aggressive carcinomas of the breast and colon.

This discovery, reported in the June 24 on-line issue of Nature Cell Biology, could provide scientists with a promising new target for the development of a drug to halt tumor invasion and metastasis, the spread of cancer from its primary site to other areas of the body.

Metastasis occurs when cancer cells penetrate the boundaries of the tumor's tissue and infiltrate the walls of blood vessels or lymph vessels, gaining a means of transport to other parts of the body far from the original tumor site where they can then grow anew. This process is unique to cancer cells and is what makes the disease so dangerous and so feared.

"A primary [cancerous] tumor can be removed," explains the study's senior author Alex Toker, Ph.D., of the department of pathology at Beth Israel Deaconess Medical Center (BIDMC) and assistant professor at Harvard Medical School. "But once the cancer has metastasized, it becomes intractable." In fact, the goal of early cancer detection is to remove the primary carcinoma before it has a chance to spread.

Scientists have known that in order for a tumor to metastasize, certain genes had to be "turned on" so that they could produce enzymes necessary to invade blood vessel walls and penetrate other tissues. Toker and his coauthors at BIDMC and at the Center for Blood Research at Harvard Medical School, set out to identify how this was happening, and began by focusing on the actions of a group of proteins known as transcription factors, including NFAT (nuclear factor of activated T cells).

NFAT, which is critical for efficient immune cell responses, was first identified in the cells of the immune system about 20 years ago. It subsequently became the target for cyclospo
'"/>

Contact: Bonnie Prescott
bprescot@caregroup.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
24-Jun-2002


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... , ... August 05, 2020 , ... Regenative Labs has ... new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to be ... a syringe. The company’s solutions are the first Wharton’s jelly allograft product to be ...
(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com , ... biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European Hematology ... Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase 1 ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced new ... for use with CRM, neurostimulation, vascular, and related devices. , Anomet Medical ... requirements, performance, and cost criteria; especially where solid wire is limited. Typical configurations ...
(Date:7/31/2020)... FRANCISCO (PRWEB) , ... July ... ... provider of cloud-based software for the life sciences industry, today announced the ... presentation platform designed specifically for Medical Science Liaisons (MSLs) and other field ...
(Date:7/18/2020)... ... July 16, 2020 , ... ... the early detection and prevention of high-burden diseases, and Centric Consulting, a business ... healthcare organizations to utilize existing data in order to identify and prioritize patients ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research using the ... pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over ... been using the zebrafish model to investigate the causes of leukaemia and its ...
Breaking Biology Technology:
Cached News: